The global Translational Regenerative Medicine market was valued at US$ 12230 million in 2023 and is anticipated to reach US$ 30580 million by 2030, witnessing a CAGR of 13.5% during the forecast period 2024-2030.

Translational Regenerative Medicine Market

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

This report aims to provide a comprehensive presentation of the global market for Translational Regenerative Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Translational Regenerative Medicine.

Report Scope

The Translational Regenerative Medicine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Translational Regenerative Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Translational Regenerative Medicine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Translational Regenerative Medicine Market Report

Report Metric	Details
Report Name	Translational Regenerative Medicine Market
Accounted market size in 2023	US$ 12230 million
Forecasted market size in 2030	US$ 30580 million
CAGR	13.5%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Stem Cell Therapy Tissue Engineering Gene Therapy
Segment by Application	Tissue Engineering Therapy Wound Healing Cartilage Repair Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Athersys, Avita Medical, AxoGen, MEDIPOST, NuVasive, Astellas Pharma, Organogenesis Holdings, Osiris Therapeutics, Pharmicell, Regenerys, Takeda Pharmaceutical, uniQure, Vericel
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Translational Regenerative Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Translational Regenerative Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Translational Regenerative Medicine Market growing?

Ans: The Translational Regenerative Medicine Market witnessing a CAGR of 13.5% during the forecast period 2024-2030.

What is the Translational Regenerative Medicine Market size in 2030?

Ans: The Translational Regenerative Medicine Market size in 2030 will be US$ 30580 million.

Who are the main players in the Translational Regenerative Medicine Market report?

Ans: The main players in the Translational Regenerative Medicine Market are Athersys, Avita Medical, AxoGen, MEDIPOST, NuVasive, Astellas Pharma, Organogenesis Holdings, Osiris Therapeutics, Pharmicell, Regenerys, Takeda Pharmaceutical, uniQure, Vericel

What are the Application segmentation covered in the Translational Regenerative Medicine Market report?

Ans: The Applications covered in the Translational Regenerative Medicine Market report are Tissue Engineering Therapy, Wound Healing, Cartilage Repair, Other

What are the Type segmentation covered in the Translational Regenerative Medicine Market report?

Ans: The Types covered in the Translational Regenerative Medicine Market report are Stem Cell Therapy, Tissue Engineering, Gene Therapy

1 Translational Regenerative Medicine Market Overview

1.1 Product Overview and Scope of Translational Regenerative Medicine

1.2 Translational Regenerative Medicine Segment by Type

1.2.1 Global Translational Regenerative Medicine Market Value Comparison by Type (2024-2030)

1.2.2 Stem Cell Therapy

1.2.3 Tissue Engineering

1.2.4 Gene Therapy

1.3 Translational Regenerative Medicine Segment by Application

1.3.1 Global Translational Regenerative Medicine Market Value by Application: (2024-2030)

1.3.2 Tissue Engineering Therapy

1.3.3 Wound Healing

1.3.4 Cartilage Repair

1.3.5 Other

1.4 Global Translational Regenerative Medicine Market Size Estimates and Forecasts

1.4.1 Global Translational Regenerative Medicine Revenue 2019-2030

1.4.2 Global Translational Regenerative Medicine Sales 2019-2030

1.4.3 Global Translational Regenerative Medicine Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Translational Regenerative Medicine Market Competition by Manufacturers

2.1 Global Translational Regenerative Medicine Sales Market Share by Manufacturers (2019-2024)

2.2 Global Translational Regenerative Medicine Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Translational Regenerative Medicine Average Price by Manufacturers (2019-2024)

2.4 Global Translational Regenerative Medicine Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Translational Regenerative Medicine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Translational Regenerative Medicine, Product Type & Application

2.7 Translational Regenerative Medicine Market Competitive Situation and Trends

2.7.1 Translational Regenerative Medicine Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Translational Regenerative Medicine Players Market Share by Revenue

2.7.3 Global Translational Regenerative Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Translational Regenerative Medicine Retrospective Market Scenario by Region

3.1 Global Translational Regenerative Medicine Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Translational Regenerative Medicine Global Translational Regenerative Medicine Sales by Region: 2019-2030

3.2.1 Global Translational Regenerative Medicine Sales by Region: 2019-2024

3.2.2 Global Translational Regenerative Medicine Sales by Region: 2025-2030

3.3 Global Translational Regenerative Medicine Global Translational Regenerative Medicine Revenue by Region: 2019-2030

3.3.1 Global Translational Regenerative Medicine Revenue by Region: 2019-2024

3.3.2 Global Translational Regenerative Medicine Revenue by Region: 2025-2030

3.4 North America Translational Regenerative Medicine Market Facts & Figures by Country

3.4.1 North America Translational Regenerative Medicine Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Translational Regenerative Medicine Sales by Country (2019-2030)

3.4.3 North America Translational Regenerative Medicine Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Translational Regenerative Medicine Market Facts & Figures by Country

3.5.1 Europe Translational Regenerative Medicine Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Translational Regenerative Medicine Sales by Country (2019-2030)

3.5.3 Europe Translational Regenerative Medicine Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Translational Regenerative Medicine Market Facts & Figures by Country

3.6.1 Asia Pacific Translational Regenerative Medicine Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Translational Regenerative Medicine Sales by Country (2019-2030)

3.6.3 Asia Pacific Translational Regenerative Medicine Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Translational Regenerative Medicine Market Facts & Figures by Country

3.7.1 Latin America Translational Regenerative Medicine Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Translational Regenerative Medicine Sales by Country (2019-2030)

3.7.3 Latin America Translational Regenerative Medicine Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Translational Regenerative Medicine Market Facts & Figures by Country

3.8.1 Middle East and Africa Translational Regenerative Medicine Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Translational Regenerative Medicine Sales by Country (2019-2030)

3.8.3 Middle East and Africa Translational Regenerative Medicine Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Translational Regenerative Medicine Sales by Type (2019-2030)

4.1.1 Global Translational Regenerative Medicine Sales by Type (2019-2024)

4.1.2 Global Translational Regenerative Medicine Sales by Type (2025-2030)

4.1.3 Global Translational Regenerative Medicine Sales Market Share by Type (2019-2030)

4.2 Global Translational Regenerative Medicine Revenue by Type (2019-2030)

4.2.1 Global Translational Regenerative Medicine Revenue by Type (2019-2024)

4.2.2 Global Translational Regenerative Medicine Revenue by Type (2025-2030)

4.2.3 Global Translational Regenerative Medicine Revenue Market Share by Type (2019-2030)

4.3 Global Translational Regenerative Medicine Price by Type (2019-2030)

5 Segment by Application

5.1 Global Translational Regenerative Medicine Sales by Application (2019-2030)

5.1.1 Global Translational Regenerative Medicine Sales by Application (2019-2024)

5.1.2 Global Translational Regenerative Medicine Sales by Application (2025-2030)

5.1.3 Global Translational Regenerative Medicine Sales Market Share by Application (2019-2030)

5.2 Global Translational Regenerative Medicine Revenue by Application (2019-2030)

5.2.1 Global Translational Regenerative Medicine Revenue by Application (2019-2024)

5.2.2 Global Translational Regenerative Medicine Revenue by Application (2025-2030)

5.2.3 Global Translational Regenerative Medicine Revenue Market Share by Application (2019-2030)

5.3 Global Translational Regenerative Medicine Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Athersys

6.1.1 Athersys Corporation Information

6.1.2 Athersys Description and Business Overview

6.1.3 Athersys Translational Regenerative Medicine Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Athersys Translational Regenerative Medicine Product Portfolio

6.1.5 Athersys Recent Developments/Updates

6.2 Avita Medical

6.2.1 Avita Medical Corporation Information

6.2.2 Avita Medical Description and Business Overview

6.2.3 Avita Medical Translational Regenerative Medicine Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Avita Medical Translational Regenerative Medicine Product Portfolio

6.2.5 Avita Medical Recent Developments/Updates

6.3 AxoGen

6.3.1 AxoGen Corporation Information

6.3.2 AxoGen Description and Business Overview

6.3.3 AxoGen Translational Regenerative Medicine Sales, Revenue and Gross Margin (2019-2024)

6.3.4 AxoGen Translational Regenerative Medicine Product Portfolio

6.3.5 AxoGen Recent Developments/Updates

6.4 MEDIPOST

6.4.1 MEDIPOST Corporation Information

6.4.2 MEDIPOST Description and Business Overview

6.4.3 MEDIPOST Translational Regenerative Medicine Sales, Revenue and Gross Margin (2019-2024)

6.4.4 MEDIPOST Translational Regenerative Medicine Product Portfolio

6.4.5 MEDIPOST Recent Developments/Updates

6.5 NuVasive

6.5.1 NuVasive Corporation Information

6.5.2 NuVasive Description and Business Overview

6.5.3 NuVasive Translational Regenerative Medicine Sales, Revenue and Gross Margin (2019-2024)

6.5.4 NuVasive Translational Regenerative Medicine Product Portfolio

6.5.5 NuVasive Recent Developments/Updates

6.6 Astellas Pharma

6.6.1 Astellas Pharma Corporation Information

6.6.2 Astellas Pharma Description and Business Overview

6.6.3 Astellas Pharma Translational Regenerative Medicine Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Astellas Pharma Translational Regenerative Medicine Product Portfolio

6.6.5 Astellas Pharma Recent Developments/Updates

6.7 Organogenesis Holdings

6.6.1 Organogenesis Holdings Corporation Information

6.6.2 Organogenesis Holdings Description and Business Overview

6.6.3 Organogenesis Holdings Translational Regenerative Medicine Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Organogenesis Holdings Translational Regenerative Medicine Product Portfolio

6.7.5 Organogenesis Holdings Recent Developments/Updates

6.8 Osiris Therapeutics

6.8.1 Osiris Therapeutics Corporation Information

6.8.2 Osiris Therapeutics Description and Business Overview

6.8.3 Osiris Therapeutics Translational Regenerative Medicine Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Osiris Therapeutics Translational Regenerative Medicine Product Portfolio

6.8.5 Osiris Therapeutics Recent Developments/Updates

6.9 Pharmicell

6.9.1 Pharmicell Corporation Information

6.9.2 Pharmicell Description and Business Overview

6.9.3 Pharmicell Translational Regenerative Medicine Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Pharmicell Translational Regenerative Medicine Product Portfolio

6.9.5 Pharmicell Recent Developments/Updates

6.10 Regenerys

6.10.1 Regenerys Corporation Information

6.10.2 Regenerys Description and Business Overview

6.10.3 Regenerys Translational Regenerative Medicine Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Regenerys Translational Regenerative Medicine Product Portfolio

6.10.5 Regenerys Recent Developments/Updates

6.11 Takeda Pharmaceutical

6.11.1 Takeda Pharmaceutical Corporation Information

6.11.2 Takeda Pharmaceutical Translational Regenerative Medicine Description and Business Overview

6.11.3 Takeda Pharmaceutical Translational Regenerative Medicine Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Takeda Pharmaceutical Translational Regenerative Medicine Product Portfolio

6.11.5 Takeda Pharmaceutical Recent Developments/Updates

6.12 uniQure

6.12.1 uniQure Corporation Information

6.12.2 uniQure Translational Regenerative Medicine Description and Business Overview

6.12.3 uniQure Translational Regenerative Medicine Sales, Revenue and Gross Margin (2019-2024)

6.12.4 uniQure Translational Regenerative Medicine Product Portfolio

6.12.5 uniQure Recent Developments/Updates

6.13 Vericel

6.13.1 Vericel Corporation Information

6.13.2 Vericel Translational Regenerative Medicine Description and Business Overview

6.13.3 Vericel Translational Regenerative Medicine Sales, Revenue and Gross Margin (2019-2024)

6.13.4 Vericel Translational Regenerative Medicine Product Portfolio

6.13.5 Vericel Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Translational Regenerative Medicine Industry Chain Analysis

7.2 Translational Regenerative Medicine Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Translational Regenerative Medicine Production Mode & Process

7.4 Translational Regenerative Medicine Sales and Marketing

7.4.1 Translational Regenerative Medicine Sales Channels

7.4.2 Translational Regenerative Medicine Distributors

7.5 Translational Regenerative Medicine Customers

8 Translational Regenerative Medicine Market Dynamics

8.1 Translational Regenerative Medicine Industry Trends

8.2 Translational Regenerative Medicine Market Drivers

8.3 Translational Regenerative Medicine Market Challenges

8.4 Translational Regenerative Medicine Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Organogenesis Holdings

Osiris Therapeutics

PHARMICELL

Regenerys Ltd

Takeda Pharmaceutical

Uniqure

Vericel

List of Tables

Table 1. Global Translational Regenerative Medicine Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Translational Regenerative Medicine Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Translational Regenerative Medicine Market Competitive Situation by Manufacturers in 2023

Table 4. Global Translational Regenerative Medicine Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Translational Regenerative Medicine Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Translational Regenerative Medicine Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Translational Regenerative Medicine Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Translational Regenerative Medicine Average Price (USD/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Translational Regenerative Medicine, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Translational Regenerative Medicine, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Translational Regenerative Medicine, Product Type & Application

Table 12. Global Key Manufacturers of Translational Regenerative Medicine, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Translational Regenerative Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Translational Regenerative Medicine as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Translational Regenerative Medicine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Translational Regenerative Medicine Sales by Region (2019-2024) & (K Units)

Table 18. Global Translational Regenerative Medicine Sales Market Share by Region (2019-2024)

Table 19. Global Translational Regenerative Medicine Sales by Region (2025-2030) & (K Units)

Table 20. Global Translational Regenerative Medicine Sales Market Share by Region (2025-2030)

Table 21. Global Translational Regenerative Medicine Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Translational Regenerative Medicine Revenue Market Share by Region (2019-2024)

Table 23. Global Translational Regenerative Medicine Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Translational Regenerative Medicine Revenue Market Share by Region (2025-2030)

Table 25. North America Translational Regenerative Medicine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Translational Regenerative Medicine Sales by Country (2019-2024) & (K Units)

Table 27. North America Translational Regenerative Medicine Sales by Country (2025-2030) & (K Units)

Table 28. North America Translational Regenerative Medicine Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Translational Regenerative Medicine Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Translational Regenerative Medicine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Translational Regenerative Medicine Sales by Country (2019-2024) & (K Units)

Table 32. Europe Translational Regenerative Medicine Sales by Country (2025-2030) & (K Units)

Table 33. Europe Translational Regenerative Medicine Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Translational Regenerative Medicine Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Translational Regenerative Medicine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Translational Regenerative Medicine Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Translational Regenerative Medicine Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Translational Regenerative Medicine Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Translational Regenerative Medicine Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Translational Regenerative Medicine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Translational Regenerative Medicine Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Translational Regenerative Medicine Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Translational Regenerative Medicine Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Translational Regenerative Medicine Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Translational Regenerative Medicine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Translational Regenerative Medicine Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Translational Regenerative Medicine Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Translational Regenerative Medicine Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Translational Regenerative Medicine Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Translational Regenerative Medicine Sales (K Units) by Type (2019-2024)

Table 51. Global Translational Regenerative Medicine Sales (K Units) by Type (2025-2030)

Table 52. Global Translational Regenerative Medicine Sales Market Share by Type (2019-2024)

Table 53. Global Translational Regenerative Medicine Sales Market Share by Type (2025-2030)

Table 54. Global Translational Regenerative Medicine Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Translational Regenerative Medicine Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Translational Regenerative Medicine Revenue Market Share by Type (2019-2024)

Table 57. Global Translational Regenerative Medicine Revenue Market Share by Type (2025-2030)

Table 58. Global Translational Regenerative Medicine Price (USD/Unit) by Type (2019-2024)

Table 59. Global Translational Regenerative Medicine Price (USD/Unit) by Type (2025-2030)

Table 60. Global Translational Regenerative Medicine Sales (K Units) by Application (2019-2024)

Table 61. Global Translational Regenerative Medicine Sales (K Units) by Application (2025-2030)

Table 62. Global Translational Regenerative Medicine Sales Market Share by Application (2019-2024)

Table 63. Global Translational Regenerative Medicine Sales Market Share by Application (2025-2030)

Table 64. Global Translational Regenerative Medicine Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Translational Regenerative Medicine Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Translational Regenerative Medicine Revenue Market Share by Application (2019-2024)

Table 67. Global Translational Regenerative Medicine Revenue Market Share by Application (2025-2030)

Table 68. Global Translational Regenerative Medicine Price (USD/Unit) by Application (2019-2024)

Table 69. Global Translational Regenerative Medicine Price (USD/Unit) by Application (2025-2030)

Table 70. Athersys Corporation Information

Table 71. Athersys Description and Business Overview

Table 72. Athersys Translational Regenerative Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 73. Athersys Translational Regenerative Medicine Product

Table 74. Athersys Recent Developments/Updates

Table 75. Avita Medical Corporation Information

Table 76. Avita Medical Description and Business Overview

Table 77. Avita Medical Translational Regenerative Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 78. Avita Medical Translational Regenerative Medicine Product

Table 79. Avita Medical Recent Developments/Updates

Table 80. AxoGen Corporation Information

Table 81. AxoGen Description and Business Overview

Table 82. AxoGen Translational Regenerative Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 83. AxoGen Translational Regenerative Medicine Product

Table 84. AxoGen Recent Developments/Updates

Table 85. MEDIPOST Corporation Information

Table 86. MEDIPOST Description and Business Overview

Table 87. MEDIPOST Translational Regenerative Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 88. MEDIPOST Translational Regenerative Medicine Product

Table 89. MEDIPOST Recent Developments/Updates

Table 90. NuVasive Corporation Information

Table 91. NuVasive Description and Business Overview

Table 92. NuVasive Translational Regenerative Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 93. NuVasive Translational Regenerative Medicine Product

Table 94. NuVasive Recent Developments/Updates

Table 95. Astellas Pharma Corporation Information

Table 96. Astellas Pharma Description and Business Overview

Table 97. Astellas Pharma Translational Regenerative Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 98. Astellas Pharma Translational Regenerative Medicine Product

Table 99. Astellas Pharma Recent Developments/Updates

Table 100. Organogenesis Holdings Corporation Information

Table 101. Organogenesis Holdings Description and Business Overview

Table 102. Organogenesis Holdings Translational Regenerative Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 103. Organogenesis Holdings Translational Regenerative Medicine Product

Table 104. Organogenesis Holdings Recent Developments/Updates

Table 105. Osiris Therapeutics Corporation Information

Table 106. Osiris Therapeutics Description and Business Overview

Table 107. Osiris Therapeutics Translational Regenerative Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 108. Osiris Therapeutics Translational Regenerative Medicine Product

Table 109. Osiris Therapeutics Recent Developments/Updates

Table 110. Pharmicell Corporation Information

Table 111. Pharmicell Description and Business Overview

Table 112. Pharmicell Translational Regenerative Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 113. Pharmicell Translational Regenerative Medicine Product

Table 114. Pharmicell Recent Developments/Updates

Table 115. Regenerys Corporation Information

Table 116. Regenerys Description and Business Overview

Table 117. Regenerys Translational Regenerative Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 118. Regenerys Translational Regenerative Medicine Product

Table 119. Regenerys Recent Developments/Updates

Table 120. Takeda Pharmaceutical Corporation Information

Table 121. Takeda Pharmaceutical Description and Business Overview

Table 122. Takeda Pharmaceutical Translational Regenerative Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 123. Takeda Pharmaceutical Translational Regenerative Medicine Product

Table 124. Takeda Pharmaceutical Recent Developments/Updates

Table 125. uniQure Corporation Information

Table 126. uniQure Description and Business Overview

Table 127. uniQure Translational Regenerative Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 128. uniQure Translational Regenerative Medicine Product

Table 129. uniQure Recent Developments/Updates

Table 130. Vericel Corporation Information

Table 131. Vericel Description and Business Overview

Table 132. Vericel Translational Regenerative Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 133. Vericel Translational Regenerative Medicine Product

Table 134. Vericel Recent Developments/Updates

Table 135. Key Raw Materials Lists

Table 136. Raw Materials Key Suppliers Lists

Table 137. Translational Regenerative Medicine Distributors List

Table 138. Translational Regenerative Medicine Customers List

Table 139. Translational Regenerative Medicine Market Trends

Table 140. Translational Regenerative Medicine Market Drivers

Table 141. Translational Regenerative Medicine Market Challenges

Table 142. Translational Regenerative Medicine Market Restraints

Table 143. Research Programs/Design for This Report

Table 144. Key Data Information from Secondary Sources

Table 145. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Translational Regenerative Medicine

Figure 2. Global Translational Regenerative Medicine Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Translational Regenerative Medicine Market Share by Type in 2023 & 2030

Figure 4. Stem Cell Therapy Product Picture

Figure 5. Tissue Engineering Product Picture

Figure 6. Gene Therapy Product Picture

Figure 7. Global Translational Regenerative Medicine Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Translational Regenerative Medicine Market Share by Application in 2023 & 2030

Figure 9. Tissue Engineering Therapy

Figure 10. Wound Healing

Figure 11. Cartilage Repair

Figure 12. Other

Figure 13. Global Translational Regenerative Medicine Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Translational Regenerative Medicine Market Size (2019-2030) & (US$ Million)

Figure 15. Global Translational Regenerative Medicine Sales (2019-2030) & (K Units)

Figure 16. Global Translational Regenerative Medicine Average Price (USD/Unit) & (2019-2030)

Figure 17. Translational Regenerative Medicine Report Years Considered

Figure 18. Translational Regenerative Medicine Sales Share by Manufacturers in 2023

Figure 19. Global Translational Regenerative Medicine Revenue Share by Manufacturers in 2023

Figure 20. The Global 5 and 10 Largest Translational Regenerative Medicine Players: Market Share by Revenue in 2023

Figure 21. Translational Regenerative Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 22. Global Translational Regenerative Medicine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 23. North America Translational Regenerative Medicine Sales Market Share by Country (2019-2030)

Figure 24. North America Translational Regenerative Medicine Revenue Market Share by Country (2019-2030)

Figure 25. U.S. Translational Regenerative Medicine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Canada Translational Regenerative Medicine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. Europe Translational Regenerative Medicine Sales Market Share by Country (2019-2030)

Figure 28. Europe Translational Regenerative Medicine Revenue Market Share by Country (2019-2030)

Figure 29. Germany Translational Regenerative Medicine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. France Translational Regenerative Medicine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. U.K. Translational Regenerative Medicine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Italy Translational Regenerative Medicine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Russia Translational Regenerative Medicine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Asia Pacific Translational Regenerative Medicine Sales Market Share by Region (2019-2030)

Figure 35. Asia Pacific Translational Regenerative Medicine Revenue Market Share by Region (2019-2030)

Figure 36. China Translational Regenerative Medicine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Japan Translational Regenerative Medicine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. South Korea Translational Regenerative Medicine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. India Translational Regenerative Medicine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Australia Translational Regenerative Medicine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Taiwan Translational Regenerative Medicine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Indonesia Translational Regenerative Medicine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Thailand Translational Regenerative Medicine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Malaysia Translational Regenerative Medicine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Philippines Translational Regenerative Medicine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Latin America Translational Regenerative Medicine Sales Market Share by Country (2019-2030)

Figure 47. Latin America Translational Regenerative Medicine Revenue Market Share by Country (2019-2030)

Figure 48. Mexico Translational Regenerative Medicine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Brazil Translational Regenerative Medicine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Argentina Translational Regenerative Medicine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Middle East & Africa Translational Regenerative Medicine Sales Market Share by Country (2019-2030)

Figure 52. Middle East & Africa Translational Regenerative Medicine Revenue Market Share by Country (2019-2030)

Figure 53. Turkey Translational Regenerative Medicine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. Saudi Arabia Translational Regenerative Medicine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. U.A.E Translational Regenerative Medicine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 56. Global Sales Market Share of Translational Regenerative Medicine by Type (2019-2030)

Figure 57. Global Revenue Market Share of Translational Regenerative Medicine by Type (2019-2030)

Figure 58. Global Translational Regenerative Medicine Price (USD/Unit) by Type (2019-2030)

Figure 59. Global Sales Market Share of Translational Regenerative Medicine by Application (2019-2030)

Figure 60. Global Revenue Market Share of Translational Regenerative Medicine by Application (2019-2030)

Figure 61. Global Translational Regenerative Medicine Price (USD/Unit) by Application (2019-2030)

Figure 62. Translational Regenerative Medicine Value Chain

Figure 63. Translational Regenerative Medicine Production Process

Figure 64. Channels of Distribution (Direct Vs Distribution)

Figure 65. Distributors Profiles

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions